Home » Topics » BioWorld

BioWorld
RSS

GENENTECH AWARDED NGF PATENT

Dec. 10, 1992

REGENERON AWARDED FIRST PATENT

Dec. 9, 1992

LIFECELL TO REDEEM WARRANTS

Dec. 9, 1992

ANTIBODY REDUCES HIV INFECTION

Dec. 9, 1992

RESULTS OF COMBINATION THERAPY

Dec. 9, 1992

NO HAMA RESPONSE TO PDL ANTIBODY

Dec. 9, 1992

GTI GENE THERAPY FOR BRAIN CANCER

Dec. 9, 1992

DU PONT EXPANDS PARTNERSHIP WITH CROP

Dec. 9, 1992

REGIMEN TARGETS CELL-SURFACE RECEPTORS

Dec. 8, 1992

APPOINTMENTS AND ADVANCEMENTS

Dec. 8, 1992

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...